Evidence map›Paper›PMID 37065348›Full record

ArticleCureus2023

Transient Recovery of Complete Atrioventricular Block Due to Maternal Anti-SS-A Antibody Through Antenatal Steroid Administration After 27 Weeks of Gestation.

Kuniya Ishii, Tsuguhiro Horikoshi, Masayo Kanai, Akio Ishiguro, Yoichi Iwamoto, Hirotaka Ishido, Akihiko Kikuchi, Satoshi Masutani

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kuniya IshiiDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Tsuguhiro HorikoshiDepartment of Obstetrics and Gynecology, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Masayo KanaiDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Akio IshiguroDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Yoichi IwamotoDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Hirotaka IshidoDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Akihiko KikuchiDepartment of Obstetrics and Gynecology, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Satoshi MasutaniDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Saitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternal anti-SS-A antibodies may cause complete atrioventricular block or myocardial damage in a fetus. Effective treatment for this has not been established. Although antenatal steroids may be a treatment option for anti-SS-A antibody-related myocarditis or atrioventricular block, a complete atrioventricular block is usually considered irreversible once established. Previous reports have indicated that, in cases where antenatal steroids were effective for atrioventricular block, they were administered earlier in the pregnancy. Here we present a case where maternal steroid administration initiated from 27 weeks, which is beyond the recommended optimal treatment period, was effective in altering a complete atrioventricular block to a grade I atrioventricular block.

Indexed as

atrioventricular blockfetalmyocarditisss-a antibodysteroid

Identifiers

PMID37065348
PMCPMC10103817
OpenAlexW4327615392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.